Found: 78
Select item for more details and to access through your institution.
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2805, doi. 10.3390/cancers16162805
- By:
- Publication type:
- Article
Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 362, doi. 10.1007/s10637-013-0061-6
- By:
- Publication type:
- Article
A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1244, doi. 10.1007/s10637-013-9945-8
- By:
- Publication type:
- Article
Pentagons in Medieval Sources and Architecture.
- Published in:
- Nexus Network Journal: Architecture & Mathematics, 2019, v. 21, n. 3, p. 681, doi. 10.1007/s00004-019-00450-7
- By:
- Publication type:
- Article
Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 63
- By:
- Publication type:
- Article
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NICI CTG BR19 study.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 55
- By:
- Publication type:
- Article
PARAMOUNT: final overall survival results of the Phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer/Randomized Phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AvAPerl (MO22089).
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 54
- By:
- Publication type:
- Article
A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 53
- By:
- Publication type:
- Article
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 51
- By:
- Publication type:
- Article
Randomized international Phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 50
- By:
- Publication type:
- Article
Randomized Phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 49
- By:
- Publication type:
- Article
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 48
- By:
- Publication type:
- Article
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 2, p. 47
- By:
- Publication type:
- Article
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Definition of a positive test result in computed tomography screening for lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
A multicenter Phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients/Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma/Predictive impact of circulating vascular endothelial growth factor in four Phase III trials evaluating bevacizumab.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, Phase 2 study.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 6, n. 4, p. 114
- By:
- Publication type:
- Article
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer/Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 6, n. 4, p. 110
- By:
- Publication type:
- Article
Efficacy and Safety Results of the Afatinib Expanded Access Program.
- Published in:
- Oncology & Therapy, 2017, v. 5, n. 1, p. 103, doi. 10.1007/s40487-017-0043-5
- By:
- Publication type:
- Article
Prevalence and Assessment of Factors Associated with COVID-19 Vaccine Hesitancy in an Ethnic Minority Oncology Patient Population.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101711
- By:
- Publication type:
- Article
Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 4, p. 577, doi. 10.1093/carcin/bgq020
- By:
- Publication type:
- Article
Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 3, p. 521, doi. 10.1093/carcin/23.3.521
- By:
- Publication type:
- Article
Molecular Testing in Lung Cancer: The Time Is Now.
- Published in:
- Current Oncology Reports, 2010, v. 12, n. 5, p. 335, doi. 10.1007/s11912-010-0118-z
- By:
- Publication type:
- Article
Three-dimensional magnetic resonance microscopy of pulmonary solitary tumors in transgenic mice.
- Published in:
- Magnetic Resonance in Medicine, 2006, v. 56, n. 3, p. 698, doi. 10.1002/mrm.21006
- By:
- Publication type:
- Article
The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy.
- Published in:
- Respiration, 2016, v. 93, n. 1, p. 1, doi. 10.1159/000453086
- By:
- Publication type:
- Article
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Differential Effects of Gefitinib and Cetuximab on Non—small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 16, p. 1185, doi. 10.1093/jnci/dji238
- By:
- Publication type:
- Article
Biomarker testing in cancer management- can one size fit all?
- Published in:
- 2022
- By:
- Publication type:
- editorial
Analysis of Gothic Architectural Details by Spatial Object Reconstruction Techniques.
- Published in:
- Periodica Polytechnica: Civil Engineering, 2017, v. 61, n. 3, p. 640, doi. 10.3311/PPci.10418
- By:
- Publication type:
- Article
Remarks on the Proportions and Dimensions Used in the Design of the Medieval Church of Zsámbék.
- Published in:
- Periodica Polytechnica Architecture, 2019, v. 50, n. 2, p. 97, doi. 10.3311/ppar.14621
- By:
- Publication type:
- Article
Frigyes Schulek's Calvinist Reformed Church in Szeged: A Particular Case of Medieval Design in Historicism.
- Published in:
- Periodica Polytechnica Architecture, 2017, v. 48, n. 1, p. 28, doi. 10.3311/PPar.11135
- By:
- Publication type:
- Article
Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells.
- Published in:
- Molecular Carcinogenesis, 2013, v. 52, n. 3, p. 218, doi. 10.1002/mc.21846
- By:
- Publication type:
- Article
PROBLEMS OF SURVEYING PROFILE SHAPES OF GOTHIC ARCHITECTURAL FRAGMENTS.
- Published in:
- Pollack Periodica, 2018, v. 13, n. 1, p. 217, doi. 10.1556/606.2018.13.1.19
- By:
- Publication type:
- Article
Do Patients Regret Having Received Systemic Treatment for Advanced Non‐Small Cell Lung Cancer: A Prospective Evaluation.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 224, doi. 10.1002/onco.13571
- By:
- Publication type:
- Article
INI‐1 (SMARCB1)–Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 738, doi. 10.1634/theoncologist.2019-0830
- By:
- Publication type:
- Article
DNA Polymerase ε Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 497, doi. 10.1634/theoncologist.2017-0034
- By:
- Publication type:
- Article
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 11, p. 1298, doi. 10.1634/theoncologist.2015-0136
- By:
- Publication type:
- Article
The Seventh Door.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. e466, doi. 10.1016/j.cllc.2020.06.017
- By:
- Publication type:
- Article
Survival Disparities in Black Patients With EGFR-mutated Non-small-cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Screening Patterns and Mortality Differences in Patients With Lung Cancer at an Urban Underserved Community.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An analysis of the relationship between metastases and cachexia in lung cancer patients.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 9, p. 2641, doi. 10.1002/cam4.841
- By:
- Publication type:
- Article
Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 4, p. 559, doi. 10.1080/0284186X.2021.1878387
- By:
- Publication type:
- Article
Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106349
- By:
- Publication type:
- Article
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2577, doi. 10.1002/cncr.35350
- By:
- Publication type:
- Article